NEW YORK (GenomeWeb News) – Genetix Group today said it plans to acquire Applied Imaging, a maker of automated imaging and image-analysis systems, for $18.3 million in cash.
Genetix is based in New Milton, on the southern coast of England. The company designs, develops, and manufactures technologies involved in a wide array of cell screening, genomic, and proteomic applications.
Applied Imaging, based in San Jose, Calif., sells instruments for cytogenetic testing, among other applications. Genetix is hoping that the acquisition will expand its cell-imaging and -analysis play and boost its presence in the US.
“Genetix's cell biology instruments and reagents complement Applied Imaging's imaging and image analysis systems and will help both companies to expand in the US, Europe, and Asia," added Genetix CEO Mark Reid.
Terms of the deal call for Genetix to pay $3.06 per share to acquire all of Applied Imaging's common stock. The transaction is expected to close in the fourth quarter.